Language:

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

EBioMedicine, 2021-09, Vol.71, p.103561-103561, Article 103561 [Peer Reviewed Journal]

2021 The Author(s) ;Attribution - NonCommercial - NoDerivatives ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103561 ;PMID: 34455390

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Author: Gallais, Floriane ; Gantner, Pierre ; Bruel, Timothée ; Velay, Aurélie ; Planas, Delphine ; Wendling, Marie-Josée ; Bayer, Sophie ; Solis, Morgane ; Laugel, Elodie ; Reix, Nathalie ; Schneider, Anne ; Glady, Ludovic ; Panaget, Baptiste ; Collongues, Nicolas ; Partisani, Marialuisa ; Lessinger, Jean-Marc ; Fontanet, Arnaud ; Rey, David ; Hansmann, Yves ; Kling-Pillitteri, Laurence ; Schwartz, Olivier ; De Sèze, Jérome ; Meyer, Nicolas ; Gonzalez, Maria ; Schmidt-Mutter, Catherine ; Fafi-Kremer, Samira
Subjects: COVID-19 ; Immunity ; Life Sciences ; Neutralizing antibodies ; Reinfection ; Research Paper ; Santé publique et épidémiologie ; SARS-CoV-2
Is Part Of: EBioMedicine, 2021-09, Vol.71, p.103561-103561, Article 103561
Description: Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting risk of reinfection and durability of vaccine protection. This is a prospective, monocentric, longitudinal, cohort clinical study. Healthcare workers (HCW) from Strasbourg University Hospital were enrolled between April 6th and May 7th, 2020 and followed up to 422 days. Serial serum samples were tested for antibodies against the Receptor Binding Domain (RBD) of the spike protein and nucleocapsid protein (N) to characterize the kinetics of SARS-CoV-2 antibodies and the incidence of reinfection. Live-neutralization assays were performed for a subset of samples before and after vaccination to analyze sensitivity to SARS-CoV-2 variants. A total of 4290 samples from 393 convalescent COVID-19 and 916 COVID-19 negative individuals were analyzed. In convalescent individuals, SARS-CoV-2 antibodies followed a triphasic kinetic model with half-lives at month (M) 11–13 of 283 days (95% CI 231–349) for anti-N and 725 days (95% CI 623–921) for anti-RBD IgG, which stabilized at a median of 1.54 log BAU/mL (95% CI 1.42–1.67). The incidence of SARS-CoV-2 infections was 12.22 and 0.40 per 100 person-years in COVID-19-negative and COVID-19-positive HCW, respectively, indicating a relative reduction in the incidence of SARS-CoV-2 reinfection of 96.7%. Live-virus neutralization assay revealed that after one year, variants D614G and B.1.1.7, but less so B.1.351, were sensitive to anti-RBD antibodies at 1.4 log BAU/mL, while IgG ≥ 2.0 log BAU/mL strongly neutralized all three variants. These latter anti-RBD IgG titers were reached by all vaccinated HCW regardless of pre-vaccination IgG levels and type of vaccine. Our study demonstrates a long-term persistence of anti-RBD antibodies that may reduce risk of reinfection. By significantly increasing cross-neutralizing antibody titers, a single-dose vaccination strengthens protection against variants. None. [Display omitted]
Publisher: Elsevier B.V
Language: English
Identifier: ISSN: 2352-3964
EISSN: 2352-3964
DOI: 10.1016/j.ebiom.2021.103561
PMID: 34455390
Source: Hyper Article en Ligne (HAL) (Open Access)
PubMed Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

2021 The Author(s) ;Attribution - NonCommercial - NoDerivatives ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103561 ;PMID: 34455390

Searching Remote Databases, Please Wait